HLA-A*2402 restricted peptide vaccine
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for HLA-A*2402 restricted peptide vaccine, covering 2008-05-14 to 2012-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer [Phase 1]